Ethyl 1-(Benzyloxy)-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate

ID: ALA4744741

PubChem CID: 162648792

Max Phase: Preclinical

Molecular Formula: C21H19N3O3

Molecular Weight: 361.40

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)c1c(C)nc(-c2cccc(C#N)c2)n1OCc1ccccc1

Standard InChI:  InChI=1S/C21H19N3O3/c1-3-26-21(25)19-15(2)23-20(18-11-7-10-17(12-18)13-22)24(19)27-14-16-8-5-4-6-9-16/h4-12H,3,14H2,1-2H3

Standard InChI Key:  CLVOGYUWBQYLIM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    3.5315   -5.3654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5303   -6.1849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2384   -6.5939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9481   -6.1844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9452   -5.3618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2366   -4.9565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6492   -4.9522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3969   -5.2817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9415   -4.6723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5302   -3.9661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7315   -4.1392    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7545   -4.7547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8597   -3.2183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6721   -3.1298    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3768   -2.5591    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0016   -2.3820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8139   -2.2934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2411   -7.4070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2409   -8.2242    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1222   -3.5947    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3459   -3.8502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7366   -3.3057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9069   -2.5094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2983   -1.9651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5211   -2.2205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3560   -3.0251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9659   -3.5659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  1  0
  5  7  1  0
  9 12  1  0
 10 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 18 19  3  0
  3 18  1  0
 11 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4744741

    ---

Associated Targets(non-human)

Plasma (649 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.40Molecular Weight (Monoisotopic): 361.1426AlogP: 3.54#Rotatable Bonds: 6
Polar Surface Area: 77.14Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.21CX LogP: 3.58CX LogD: 3.58
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.63Np Likeness Score: -1.39

References

1. Lei Y,Zhang B,Liu D,Zhao J,Dai X,Gao J,Mao Q,Feng Y,Zhao J,Lin F,Duan Y,Zhang Y,Bao Z,Yang Y,Mou Y,Wang S.  (2020)  Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y and P2Y as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor.,  63  (24): [PMID:33307675] [10.1021/acs.jmedchem.0c01524]

Source